is an online platform that serves as a comprehensive source of news for the cannabis, hemp, and CBD industries. The website covers a range of topics, from interviews and business news to health studies, state regulations, and conferences surrounding cannabis.

The site provides readers with up-to-date news on breakthroughs in health studies related to cannabis products. Recent articles highlighted include the promising role of Cannabidiol in prostate cancer treatment, as well as a significant grant awarded to Weill Cornell Medicine for a study on the effects of cannabis use in HIV-related brain issues.

In addition to health-related stories, also offers insights into the business aspects of the cannabis industry. It features articles that analyze the struggles faced by a majority of businesses in the cannabis industry amid worsening conditions. also provides a platform for discussions on state and international regulations pertaining to cannabis. Recent posts talk about a significant shift in Portugal's discourse on cannabis legalization. News regarding the recommended removal of cannabinoids from the NCAA's list of banned substances is also covered, showing the site's commitment to covering major developments at both the national and international levels.

Growing methods of cannabis, such as hydroponics vs. growboxes, are also discussed on the site, making it a useful resource for those interested in cultivation. It also delves into the science behind various cannabinoids, such as Cannabigerolic Acid (CBGA) and cannabigerovarinic acid (CBGVA), aiding consumers to make informed choices about the products they use.

Lastly, keeps its readers informed about international views on cannabis. For instance, one of the articles covers the Thai Prime Minister's stance on medicinal cannabis use in opposition to its recreational use. This broad coverage of international news sets the platform apart, making it a comprehensive resource for anyone interested in the global cannabis industry.